2004
DOI: 10.1016/s0968-0160(03)00041-3
|View full text |Cite
|
Sign up to set email alerts
|

The use of chondrogide membrane in autologous chondrocyte implantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
136
1
12

Year Published

2006
2006
2017
2017

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 191 publications
(150 citation statements)
references
References 12 publications
1
136
1
12
Order By: Relevance
“…Moreover, the periosteum exerts potential immunogenic effects (26). Therefore, some attempts were made to replace the periosteum using different resorbable scaffolds (27)(28)(29)(30)(31)(32)(33). In our model, the chondrospheres presumably adhered to the cartilage surface border by surface tension forces.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the periosteum exerts potential immunogenic effects (26). Therefore, some attempts were made to replace the periosteum using different resorbable scaffolds (27)(28)(29)(30)(31)(32)(33). In our model, the chondrospheres presumably adhered to the cartilage surface border by surface tension forces.…”
Section: Discussionmentioning
confidence: 99%
“…As an alternative to periosteal flaps, collagen membranes, e.g. ChondroGide  (Geistlich Biomaterials, Wolhusen, Switzerland), are used during the second generation of ACT, resulting in satisfactory repair without hypertrophic development at a 1 year post-surgery arthroscopy (Haddo et al, 2004).…”
Section: Autologous Chondrocyte Transplantation and Matrix-associatedmentioning
confidence: 99%
“…The outcome of these chondrocyte-based techniques is generally quite good (Minas, 2001;Peterson et al, 2000) but in many cases results in the formation of non-hyaline cartilage repair tissue with inferior mechanical properties and limited durability (Pelttari et al, 2009). ACI has several technical limitations: a) obtaining cartilage explants requires an additional surgical intervention, adding to the articular cartilage damage that increases the osteoarthritic process (Marcacci et al, 2002); b) in vitro chondrocyte proliferation must be limited because the capacity to produce stable cartilage in vivo is gradually reduced when cell divisions are increased (Dell´Accio et al, 2001); c) aging reduces the cellular density of the cartilage, which impacts chondrocyte proliferation capacity in vitro (Menche et al, 1998) and the chondrogenic potential of the periosteum (O´Driscoll & Fitzsimmons, 2001), d) cell culture procedures take too long (3 to 6 weeks) and increase the risk of contamination, e) risk of leakage of transplanted chondrocytes from the cartilage defects, f) the effects of gravity causing the chondrocytes to sink to the dependent side of the defect, resulting in an unequal distribution of cells that hampers the homogenous regeneration of the cartilage (Díaz-Prado et al, 2010c;Sohn et al, 2002), g) not the least the reacquisition of phenotypes of dedifferentiated chondrocytes in a monolayer culture (Kimura et al, 1984;Benya & Shaffer, 1982) and h) hypertrophy of tissue (Steinwachs & Kreuz, 2007;Haddo et al, 2004). The use of periosteum membrane poses constraints and the need for wide surgical incision, hypertrophy of the periosteum peripheral implant and its potential for ectopic calcification.…”
Section: Autologous Chondrocyte Implantationmentioning
confidence: 99%
“…The use of periosteum membrane poses constraints and the need for wide surgical incision, hypertrophy of the periosteum peripheral implant and its potential for ectopic calcification. As an alternative it has been proposed the use of a membrane collagen type I/III (Haddo et al, 2004;Krishnan et al, 2006;Robertson et al, 2007). The use of both kinds of membranes shows no significant differences in the clinical assessment, although arthroscopic analysis showed that after implantation of periosteum a substantial number of patients required a cleanup of the peripheral hypertrophy (Gooding et al, 2006).…”
Section: Autologous Chondrocyte Implantationmentioning
confidence: 99%